Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.130
-0.030 (-0.95%)
Jun 25, 2025, 4:00 PM - Market closed
Biomerica Employees
Biomerica had 64 employees as of May 31, 2024. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$88,719
Profits / Employee
-$75,781
Market Cap
7.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BMRA News
- 19 days ago - Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair - GlobeNewsWire
- 20 days ago - Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - GlobeNewsWire
- 4 weeks ago - Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System - GlobeNewsWire
- 7 weeks ago - PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - GlobeNewsWire
- 2 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - GlobeNewsWire
- 2 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - GlobeNewsWire
- 2 months ago - Biomerica Announces Reverse Stock Split - GlobeNewsWire
- 4 months ago - Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis - GlobeNewsWire